IE44911L - Rhinotracheitis vaccine. - Google Patents

Rhinotracheitis vaccine.

Info

Publication number
IE44911L
IE44911L IE770654A IE65477A IE44911L IE 44911 L IE44911 L IE 44911L IE 770654 A IE770654 A IE 770654A IE 65477 A IE65477 A IE 65477A IE 44911 L IE44911 L IE 44911L
Authority
IE
Ireland
Prior art keywords
vaccine
feline viral
viral rhinotracheitis
prepared
calicivirus
Prior art date
Application number
IE770654A
Other versions
IE44911B1 (en
Original Assignee
Norden Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norden Lab Inc filed Critical Norden Lab Inc
Publication of IE44911L publication Critical patent/IE44911L/en
Publication of IE44911B1 publication Critical patent/IE44911B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265Infectious rhinotracheitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08Radiation
    • A61L2/10Ultraviolet radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/16011Caliciviridae
    • C12N2770/16034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/819Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A modified live feline viral rhinotracheitis vaccine is prepared by treating with ultraviolet light a feline viral rhinotracheitis virus which has been subjected to chemical treatment with mutagens. A combination feline viral rhinotracheitis-calicivirus vaccine is prepared by combining a modified live feline viral rhinotracheitis virus and naturally-occurring calicivirus. [US4031204A]
IE654/77A 1976-03-30 1977-03-29 Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom IE44911B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/671,792 US4031204A (en) 1976-03-30 1976-03-30 Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom

Publications (2)

Publication Number Publication Date
IE44911L true IE44911L (en) 1977-09-30
IE44911B1 IE44911B1 (en) 1982-05-19

Family

ID=24695906

Family Applications (1)

Application Number Title Priority Date Filing Date
IE654/77A IE44911B1 (en) 1976-03-30 1977-03-29 Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom

Country Status (13)

Country Link
US (1) US4031204A (en)
JP (2) JPS52120117A (en)
AU (1) AU510744B2 (en)
BE (1) BE852756A (en)
CA (1) CA1085724A (en)
DE (1) DE2713371A1 (en)
FR (1) FR2346022A1 (en)
GB (1) GB1580844A (en)
IE (1) IE44911B1 (en)
LU (1) LU77030A1 (en)
NL (1) NL7703197A (en)
NZ (1) NZ183618A (en)
ZA (1) ZA771893B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
JPS5576819A (en) * 1978-11-30 1980-06-10 Wellcome Found Attenuated feline infectious peritonitis virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
US4711778A (en) * 1980-07-30 1987-12-08 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
JPS59501161A (en) * 1982-06-10 1984-07-05 パ−セル・ロバ−ト・エツチ Lipid virus inactivation method
US4511556A (en) * 1982-06-10 1985-04-16 The United States Of America As Represented By The Department Of Health And Human Services Inactivation of a lipid virus
US4581231A (en) * 1982-06-10 1986-04-08 The United States Of America As Represented By The Secretary Of Health And Human Services Inactivation of viruses containing essential lipids
CA1208551A (en) * 1982-12-27 1986-07-29 Ricardo H. Landaburu Solvent treatment of plasma protein products
CA1237668A (en) * 1983-02-25 1988-06-07 Novagene Inc. Thymidine kinase-negative temperature resistant bovine herpes-virus-1 mutant as vaccine
US4615886A (en) * 1983-08-31 1986-10-07 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus
US4490361A (en) * 1983-12-02 1984-12-25 Alpha Therapeutic Corporation Virus inactivating heat treatment of plasma fractions
US5716822A (en) * 1989-07-21 1998-02-10 Pharmacia & Upjohn Company Feline calicivirus capsid gene and protein
ZA927037B (en) * 1991-09-30 1993-03-29 Akzo Nv Respiratory disease vaccine for cats.
US7306807B2 (en) * 2004-09-13 2007-12-11 Wyeth Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
GB2509940A (en) * 2013-01-18 2014-07-23 John Ogino Vaccine production via irradiation of pathogenic cultures
US10188725B2 (en) 2015-12-14 2019-01-29 Elanco Us Inc. Hybrid core feline vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259546A (en) * 1962-06-01 1966-07-05 Canadian Patents Dev Treatment of viruses
US3914408A (en) * 1973-10-12 1975-10-21 Univ Nebraska Vaccine for neonatal calf diarrhea
CA1058074A (en) * 1974-03-25 1979-07-10 Pitman-Moore Feline rhinotracheitis vaccine and production thereof

Also Published As

Publication number Publication date
JPS62115279A (en) 1987-05-26
NL7703197A (en) 1977-10-04
GB1580844A (en) 1980-12-03
US4031204A (en) 1977-06-21
LU77030A1 (en) 1977-07-22
FR2346022A1 (en) 1977-10-28
JPS52120117A (en) 1977-10-08
JPS6257307B2 (en) 1987-11-30
DE2713371A1 (en) 1977-10-13
NZ183618A (en) 1979-12-11
JPS6216933B2 (en) 1987-04-15
FR2346022B1 (en) 1981-07-10
AU510744B2 (en) 1980-07-10
IE44911B1 (en) 1982-05-19
CA1085724A (en) 1980-09-16
ZA771893B (en) 1978-03-29
AU2329177A (en) 1978-09-21
BE852756A (en) 1977-09-22
DE2713371C2 (en) 1989-01-05

Similar Documents

Publication Publication Date Title
IE44911L (en) Rhinotracheitis vaccine.
JPS536428A (en) Preventing method of virus infection
SE429403B (en) PROCEDURE FOR PREPARING Aqueous Preparation for Skin Treatment, SPECIFICALLY FOR TREATING ACN
JPS5415867A (en) Removing of harmful gas by deodorizing aqueous fertilizer
JPS51143569A (en) A wet exhaust gas treatment process
PT67868A (en) Improved live newcastle disease virus vaccine
NZ183907A (en) Attenuated live equine herpes i (equine rhinopneumonitis) virus and vaccine
JPS53131270A (en) Treating method for exhaust gas
ZA794204B (en) Neutralizing or destroying viruses
NO832245L (en) CONCENTRATED, Aqueous Fabric Softener Mixture and Procedures for Preparation thereof
ES466758A1 (en) Respiratory syncytical virus vaccine
JPS5241447A (en) Sludge treating method
JPS5390178A (en) Water purifying method
NO874008D0 (en) PROCEDURE FOR THE TREATMENT OF FISH BY DIVISION AND APPROACH TO THE PROCEDURE.
JPS5216859A (en) Method of treating alkali waste water
JPS53148548A (en) Hairdye
JPS51119156A (en) Treating method of excrements of livestock
JPS5218060A (en) Method of treating polyvinyl alcohol-containing drainage
JPS534463A (en) Color receiving tube
SU651792A1 (en) Method of treating tumors of tracheolaryngeal localization
JPS51139169A (en) Waste water treatment
JPS521955A (en) Reduction treatment of night soil
JPS5221334A (en) Preventive and treatable agent against fish viral diseases
JPS5276427A (en) Preparation of anti-plant-virus fraction
JPS53115678A (en) Method for sterilizing selective permeable membrane